Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Dec 6, 2022--
The "Custom Antibody Service Market, by Service Type, by Product Type, by Source, by Application, by End Users, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
Antibodies are produced by the immune system in response to invading pathogens. The invading bacteria, virus, or other foreign molecules are collectively called as antigens. Antibodies are proteins, or polypeptides which have specific antigen recognition sites. Antibodies are formed by B-cells of the immune system.
When an antibody is needed against a specific antigen, but it isn't available from a supplier, it is possible to have antibodies made via custom antibody production. These antibodies are of two types depending on how they are generated and harvested: polyclonal or monoclonal. Polyclonal antibodies are capable of recognizing multiple sites on an antigen. They are derived from different B cell lineages. Monoclonal antibodies recognize only one epitope or site on an antigen, and are derived from a single B-cell line. There are six steps to polyclonal antibody production:
1. Peptide design
2. Peptide synthesis
3. Animal immunization
4. Serum collection
5. Titer analysis
6. Final antibody purification
Thus, key market players provide services in all or some of these above mentioned steps.
Market Dynamics
Increasing launches of new customized antibody services by key market players and advantages of using antibodies for various applications is expected to provide lucrative growth to Global Custom Antibody Service Market for the forecast period.
In addition, increase in the funding by various organizations in R&D is expected to drive the growth of global custom antibody service market over the forecast period. For instance, according to an article published by R&D world on April 20, 2022, the U.S. industrial organizations are expected to collectively invest US$ 447 billion in R&D of health care. Moreover, the U.S. federal government is expected to invest US$ 181.4 billion in R&D of health care in 2022.
Key features of the study:
Detailed Segmentation:
Global Custom Antibody Service market, By Service Type:
Global Custom Antibody Service market, By Product Type:
Global Custom Antibody Service market, By Source:
Global Custom Antibody Service market, By Application:
Global Custom Antibody Service market, By End Users:
Global Custom Antibody Service Market, By Region
Company Profiles
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Global Custom Antibody Service Market Insights
4. Global Custom Antibody Service Market - Impact of Coronavirus (Covid-19) Pandemic
5. Global Custom Antibody Service Market, By Service Type, 2017 - 2030 (US$ Million)
6. Global Custom Antibody Service Market, By Product Type, 2017 - 2030 (US$ Million)
7. Global Custom Antibody Service Market, By Source, 2017 - 2030 (US$ Million)
8. Global Custom Antibody Service Market, By Application, 2017 - 2030, (US$ Mn)
9. Global Custom Antibody Service Market, By End User, 2017 - 2030, (US$ Mn)
10. Global Custom Antibody Service Market, By Region, 2017 - 2030, (US$ Mn)
11. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/rf3yc3
View source version on businesswire.com:https://www.businesswire.com/news/home/20221206005953/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/06/2022 01:33 PM/DISC: 12/06/2022 01:33 PM
http://www.businesswire.com/news/home/20221206005953/en